You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

A Digest of Latest Clinical Data With GLP-1 Receptor Agonists

  • Authors: Filip K. Knop, MD PhD; Subodh Verma MD, PhD, FRCSC, FAHA
  • CPD Released: 7/10/2020
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 7/10/2021, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US and non-UK diabetologists, endocrinologists, cardiologists, and primary care physicians.

The goal of this activity is to increase physician awareness of key clinical study results with long-acting glucagon-like peptide 1 (GLP-1) receptor agonists.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Recent clinical study results with long-acting GLP-1 receptor agonists


Disclosures

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.


Faculty

  • Filip K. Knop, MD, PhD

    Professor of Endocrinology
    Head, Center for Clinical Metabolic Research
    Gentofte Hospital
    University of Copenhagen
    Copenhagen, Denmark

    Disclosures

    Disclosure: Filip K. Knop , MD, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Amgen Inc.; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Carmot Therapeutics; Eli Lilly and Company; Merck & Co., Inc.; Mundipharma; Novo Nordisk, Sanofi; Zealand Pharma
    Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Lupin; MedImmune Inc.; Merck & Co., Inc.; Mundipharma; Norgine; Novo Nordisk; Sanofi; Zeland Pharma
    Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Gubra; Novo Nordisk; Sanofi; Zealand Pharma
    Other: Antag Therapeutics ApS

  • Subodh Verma MD, PhD, FRCSC, FAHA

    Cardiac Surgeon, St. Michael’s Hospital
    Unity Health Toronto
    Scientist, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of Unity Health Toronto
    Professor of Surgery and Pharmacology & Toxicology
    University of Toronto
    Toronto, Ontario, Canada
    Canada Research Chair in Cardiovascular Surgery

    Disclosures

    Disclosure: Subodh Verma, MD, PhD, FRCSC, FAHA, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Amgen Inc.; AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; EOCI; HLS Therapeutics; Janssen Pharmaceuticals; Merck & Co., Inc.; Novo Nordisk; Sanofi
    Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; EOCI; HLS Therapeutics; Janssen Pharmaceuticals; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk; Sanofi; Sun Pharmaceuticals; Toronto Knowledge Translation Working Group
    Received grants for clinical research from: Amarin Corporation plc; Amgen Inc.; AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; HLS Therapeutics; Janssen Pharmaceuticals; Merck & Co., Inc.

Editor

  • Philippa M. Berman, BA(Hons), MBBS

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Philippa M. Berman, BA(Hons), MBBS, has disclosed no relevant financial relationships.

Content Reviewer

  • Anjali Mehra, MD

    Lead Medical Education Director

    Disclosures

    Disclosure: Anjali Mehra, MD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.25 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

A Digest of Latest Clinical Data With GLP-1 Receptor Agonists

Authors: Filip K. Knop, MD PhD; Subodh Verma MD, PhD, FRCSC, FAHAFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 7/10/2020

Valid for credit through: 7/10/2021, 11:59 PM EST

processing....

ADA = American Diabetes Association
AE = adverse event
ALT = alanine aminotransferase (ALT)
AST = aspartate aminotransferase
BMI = body mass index
DKD = diabetic kidney disease
DPP-4 = dipeptidyl peptidase 4
DSST = Digit Symbol Substitution Test
eGFR = estimated glomerular filtration rate
GFR = glomerular filtration rate
GI = gastrointestinal
GIP = glucose-dependent insulinotropic polypeptide
GLP-1 = glucagon-like peptide 1
K-18 = keratin-18
MACE = major adverse cardiac events
MoCA = Montreal Cognitive Assessment
OAD = oral antidiabetic drug
PBO = placebo
Pro-C3 = procollagen III
RA = receptor agonist
SD = standard deviation
SGLT-2 = sodium-glucose co-transporter-2
SU = sulfonylurea
T2D = type 2 diabetes
TZD = thiazolidinedione
UACR = urinary albumin-creatinine ratio

« Return to: A Digest of Latest Clinical Data With GLP-1 Receptor Agonists
  • Print